A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer

被引:134
|
作者
Hunter, DJ
Hankinson, SE
Hough, H
Gertig, DM
GarciaClosas, M
Spiegelman, D
Manson, JE
Colditz, GA
Willett, WC
Speizer, FE
Kelsey, K
机构
[1] BRIGHAM & WOMENS HOSP,DEPT MED,CHANNING LAB,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,BOSTON,MA 02115
[3] HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,CAMBRIDGE,MA 02138
[4] HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,CAMBRIDGE,MA 02138
[5] HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,CAMBRIDGE,MA 02138
[6] HARVARD UNIV,SCH PUBL HLTH,DEPT ENVIRONM HLTH,CAMBRIDGE,MA 02138
[7] HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,CAMBRIDGE,MA 02138
关键词
D O I
10.1093/carcin/18.11.2127
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Polymorphisms in the N-acetyltransferase 2 (NAT2) gene are determinants of the rate of metabolic activation of carcinogenic compounds such as aryl aromatic amines, Homozygosity for any combination of three variant alleles in Caucasians defines 'slow' acetylators; presence of one or two wild-type alleles characterizes 'rapid' acetylators, Although most previous studies have not observed an overall elevation in risk of breast cancer among slow acetylators, a recent study observed that cigarette smoking was associated with a large increase in risk of breast cancer among slow acetylators. We assessed the relation between NAT2 acetylation status and breast cancer risk, and its interaction with smoking, in a prospective study of mainly Caucasian US women, Four hundred and sixty-six incident cases who were diagnosed with breast cancer after giving a blood specimen in 1989-90 were matched to 466 controls in a nested case-control study, NAT2 genotype was determined using PCR-RFLP assays. The multivariate relative risk (RR) comparing slow with rapid acetylators was 0.9 (95 % CI 0.7-1.2), Among slow acetylators, current smoking immediately prior to diagnosis was not associated with a significant elevation in risk compared with never smoking rapid acetylators (RR 1.4, 95 % CI 0.7-2.6), No significant association was seen between pack-years of smoking and risk of breast cancer among either slow or fast acetylators, A non-significant elevation in risk was observed among women who smoked for greater than or equal to 5 years prior to first pregnancy and were rapid acetylators, compared with never smoking rapid acetylators (RR = 1.5, 95% CI 0.9-2.6). In analyses limited to 706 post-menopausal women, the elevated risks for current smokers immediately prior to diagnosis who were slow acetylators compared with never smokers who were fast acetylators were slightly stronger but still not statistically significant, In summary, we observed little evidence of an association between NAT2 genotype and breast cancer, In this prospective study, cigarette smoking was not appreciably associated with breast cancer among either slow or fast NAT2 acetylators.
引用
收藏
页码:2127 / 2132
页数:6
相关论文
共 50 条
  • [1] Tobacco smoking, NAT2 acetylation genotype and breast cancer risk
    Lissowska, Jolanta
    Brinton, Louise A.
    Zatonski, Witold
    Blair, Aaron
    Bardin-Mikolajczak, Alicja
    Peplonska, Beata
    Sherman, Mark E.
    Szeszenia-Dabrowska, Neonila
    Chanock, Stephen
    Garcia-Closas, Montserrat
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (08) : 1961 - 1969
  • [2] Cigarette smoking, NAT2 genotype, and risk of prostate cancer.
    Huang, HH
    Vena, JE
    Freudenheim, JL
    Ambrosone, CB
    Marshall, JR
    Nemoto, T
    Graham, S
    Laughlin, R
    Shields, PG
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (11) : S70 - S70
  • [3] A prospective study of acetylation genotype, cigarette smoking, and risk of breast cancer.
    Hunter, D
    Hankinson, S
    Hough, H
    Kelsey, K
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 237 - 237
  • [4] Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study
    Lubin, Jay H.
    Kogevinas, Manolis
    Silverman, Debra
    Malats, Nuria
    Garcia-Closas, Montserrat
    Tardon, Adonina
    Hein, David W.
    Garcia-Closas, Reina
    Serra, Consol
    Dosemeci, Mustafa
    Carrato, Alfredo
    Rothman, Nathaniel
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2007, 36 (01) : 236 - 241
  • [5] N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer
    Alberg, AJ
    Daudt, A
    Huang, HY
    Hoffman, SC
    Comstock, GW
    Helzlsouer, KJ
    Strickland, PT
    Bell, DA
    CANCER DETECTION AND PREVENTION, 2004, 28 (03): : 187 - 193
  • [6] NAT2, GSTM-1, cigarette smoking, and risk of colon cancer
    Slattery, ML
    Potter, JD
    Samowitz, W
    Bigler, J
    Caan, B
    Leppert, M
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (12) : 1079 - 1084
  • [7] Active cigarette smoking and the risk of breast cancer at the level of N-acetyltransferase 2 (NAT2) gene polymorphisms
    Kasajova, Petra
    Holubekova, Veronika
    Mendelova, Andrea
    Lasabova, Zora
    Zubor, Pavol
    Kudela, Erik
    Biskupska-Bodova, Kristina
    Danko, Jan
    TUMOR BIOLOGY, 2016, 37 (06) : 7929 - 7937
  • [8] NAT2 slow acetylator genotype as an important modifier of breast cancer risk
    Sillanpää, P
    Hirvonen, A
    Kataja, V
    Eskelinen, M
    Kosma, VM
    Uusitupa, M
    Vainio, H
    Mitrunen, K
    INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (04) : 579 - 584
  • [9] Association of Slow Acetylation Profile of NAT2 with Breast and Gastric Cancer Risk in Brazil
    Fernandes, Marianne Rodrigues
    De Carvalho, Darlen Cardoso
    Campos Ribeiro Dos Santos, Andrea Kelly
    Batista Dos Santos, Sidney Emanuel
    De Assumpcao, Paulo Pimentel
    Rodriguez Burbano, Rommel Mario
    Carneiro Dos Santos, Ney Pereira
    ANTICANCER RESEARCH, 2013, 33 (09) : 3683 - 3689
  • [10] Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer
    Sorensen, Mette
    Autrup, Herman
    Olsen, Anja
    Tjonneland, Anne
    Overvad, Kim
    Raaschou-Nielsen, Ole
    CANCER LETTERS, 2008, 266 (02) : 186 - 193